Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUPRENORPHINE\NALOXONE Cause Salivary hypersecretion? 37 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Salivary hypersecretion have been filed in association with BUPRENORPHINE\NALOXONE. This represents 0.2% of all adverse event reports for BUPRENORPHINE\NALOXONE.

37
Reports of Salivary hypersecretion with BUPRENORPHINE\NALOXONE
0.2%
of all BUPRENORPHINE\NALOXONE reports
0
Deaths
1
Hospitalizations

How Dangerous Is Salivary hypersecretion From BUPRENORPHINE\NALOXONE?

Of the 37 reports, 1 (2.7%) required hospitalization.

Is Salivary hypersecretion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BUPRENORPHINE\NALOXONE. However, 37 reports have been filed with the FAERS database.

What Other Side Effects Does BUPRENORPHINE\NALOXONE Cause?

Drug dependence (4,755) Drug withdrawal syndrome (3,167) Pain (2,472) Off label use (1,946) Nausea (1,899) Overdose (1,749) Emotional distress (1,696) Vomiting (1,370) Foetal exposure during pregnancy (1,309) Anxiety (1,307)

What Other Drugs Cause Salivary hypersecretion?

CLOZAPINE (1,349) ARIPIPRAZOLE (497) RISPERIDONE (485) OLANZAPINE (449) QUETIAPINE (299) CARBIDOPA\LEVODOPA (248) HALOPERIDOL (216) DIAZEPAM (185) CLONAZEPAM (179) LORAZEPAM (165)

Which BUPRENORPHINE\NALOXONE Alternatives Have Lower Salivary hypersecretion Risk?

BUPRENORPHINE\NALOXONE vs BUPROPION BUPRENORPHINE\NALOXONE vs BUPROPION HYDROBROMIDE BUPRENORPHINE\NALOXONE vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE BUPRENORPHINE\NALOXONE vs BUPROPION\NALTREXONE BUPRENORPHINE\NALOXONE vs BUROSUMAB

Related Pages

BUPRENORPHINE\NALOXONE Full Profile All Salivary hypersecretion Reports All Drugs Causing Salivary hypersecretion BUPRENORPHINE\NALOXONE Demographics